- Companies
- SpecialtyCare
SpecialtyCare Acquisition, Valuation, Funding & Investors
SpecialtyCare was acquired by Morgan Stanley Infrastructure Partners for $1.3B in October 2021.
SpecialtyCare acquisition price
$1.3B
Acquired by Morgan Stanley Infrastructure Partners · Oct 2021
Cumulative funding SpecialtyCare raised
$600K
across 1 funding round
About SpecialtyCare
SpecialtyCare is a provider of outsourced clinical services including perfusion, autotransfusion, and intraoperative neuromonitoring for hospitals across the United States. Headquartered in Brentwood, Tennessee, and founded in 2006, the company deploys certified technicians to over 1,000 facilities. It supports cardiac, orthopedic, and neuro surgeries with technology-enabled services aimed at improving patient safety and surgical efficiency. SpecialtyCare integrates with operating room teams nationwide.
Founded
2006
HQ
Website
Status
Acquired
Customer focus
B2B
Revenue model
Services
Valuation
$1.3B (acquired Oct 2021)
Sectors
SpecialtyCare Acquisition
SpecialtyCare was acquired by Morgan Stanley Infrastructure Partners for $1.3B on 29 October 2021.
Before the acquisition SpecialtyCare had raised $600K across 1 funding round.
SpecialtyCare operates the leading network of outsourced clinical services to hospital operating rooms in the U.S., supporting over 500,000 procedures annually with more than 1,500 clinicians across 1,200+ hospitals and 13,500 physicians in 46 states. It is the leading provider of cardiovascular perfusion, extracorporeal membrane oxygenation (ECMO), intraoperative neuromonitoring (IONM), autologous perfusion services (ATS), sterile processing, endoscopic support, and surgical assistance. On October 29, 2021, investment funds managed by Morgan Stanley Infrastructure Partners (MSIP) acquired SpecialtyCare from Kohlberg & Company. MSIP views SpecialtyCare as providing essential solutions in an industry with strong tailwinds via a contracted business model, planning to support its growth. SpecialtyCare's CEO highlighted alignment with MSIP to invest in the team, enhance culture, and improve patient outcomes. Financial terms were not disclosed in press releases or announcements from MSIP, BusinessWire, or legal advisors.
| Acquirer | Date | Type | Price |
|---|---|---|---|
| 29 Oct 2021 | PE buyout | $1.3B |
SpecialtyCare Funding History
SpecialtyCare has raised a total of $600K across 1 funding round.
SpecialtyCare funding rounds
| Date | Stage | Raised |
|---|---|---|
| Aug 2013 | Seed | $600K |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAcquisitions by SpecialtyCare
SpecialtyCare has acquired 5 companies to date.
Last acquisition by SpecialtyCare was on November 19th 2019. SpecialtyCare acquired Synapse Neuromonitoring for undisclosed valuation.
Latest Acquisitions by SpecialtyCare
| Description | - | Neuropath provides intraoperative neuromonitoring (IONM) and diagnostic support services for spine, cranial, and surgical procedures. The national provider assists surgeons and healthcare facilities in real-time nerve protection during operations. Based in the United States, Neuropath operates across multiple states with certified technologists. | Precedent Health is a Brentwood-headquartered provider of managed care services founded in 2010. The company builds hospital partnerships and specialty networks for behavioral health and oncology in Tennessee. Precedent Health negotiates contracts with payers for bundled payments and value-based care models. It serves regional health systems in Nashville and Memphis metropolitan areas. | Sentient Medical Systems is a provider of intraoperative neurophysiological monitoring and neurodiagnostic services across the United States. The company supports hundreds of healthcare facilities and surgeons with round-the-clock coverage. Services include monitoring brain and spinal cord function during high-risk surgical procedures to mitigate neurological damage. Headquartered in Minnesota, Sentient deploys certified technologists and advanced neuromonitoring technologies in operating rooms nationwide, enhancing patient safety outcomes in neurosurgery, orthopedics, and spine interventions. | |
| HQ Country | |||||
| HQ City | - | Atlanta, GA | - | Baltimore, MD | |
| Deal Date | 19 Nov 2019 | 23 Apr 2019 | 9 Aug 2018 | 27 Oct 2016 | |
| Valuation | undisclosed | undisclosed | undisclosed | undisclosed | |
| EV/Revenue | |||||
| EV/EBITDA | |||||
This data is available for Pro users. Sign up to see all SpecialtyCare acquisitions and their M&A valuation multiples. Start Free Trial | |||||
SpecialtyCare Competitors
SpecialtyCare competitors include listed companies like TKC, SMS, FESCO Group and Zensar Technologies, and private ones like Pilot and IntelyCare.
| Company | HQ | Status | Revenue | EBITDA | Valuation | Revenue Multiple |
|---|---|---|---|---|---|---|
| Private | $43M | - | $1.3B | 30.5x | ||
| Publicly listed | $533M | $135M | $1.3B | 2.0x | ||
| Publicly listed | $414M | ($62M) | $1.4B | 3.2x | ||
| Private | - | - | $1.1B | - | ||
| Publicly listed | $6.7B | $296M | $1.1B | 0.0x | ||
| Publicly listed | $593M | $105M | $1B | 1.2x |
SpecialtyCare Public Comps
SpecialtyCare is no longer listed, but its public comps include TKC, SMS, FESCO Group, Zensar Technologies, BLS International, McMillan Shakespeare, Concentrix, Amano, transcosmos and Beyondsoft.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $533M | $135M | 2.0x | 2.0x | 7.9x | - | |||
| $414M | ($62M) | 3.3x | 3.2x | (21.8x) | 19.8x | |||
| $6.7B | $296M | 0.0x | 0.0x | 0.5x | 0.7x | |||
| $593M | $105M | 1.3x | 1.2x | 7.3x | 7.9x | |||
| $313M | $89M | 2.9x | 2.6x | 10.0x | 9.4x | |||
| $336M | $179M | 4.4x | 3.5x | 8.4x | 11.4x | |||
| $9.8B | ($231M) | 0.6x | 0.6x | (26.1x) | 4.2x | |||
| $1.1B | $232M | 1.3x | 1.3x | 6.2x | 6.6x | |||
This data is available for Pro users. Sign up to see all SpecialtyCare competitors and their valuation data. Start Free Trial | ||||||||
Common questions about SpecialtyCare
| When was SpecialtyCare founded? | SpecialtyCare was founded in 2006. |
| Where is SpecialtyCare headquartered? | SpecialtyCare is headquartered in United States. |
| Is SpecialtyCare publicly listed? | No, SpecialtyCare was acquired by Morgan Stanley Infrastructure Partners in October 2021. |
| Who acquired SpecialtyCare? | SpecialtyCare was acquired by Morgan Stanley Infrastructure Partners in October 2021. |
| How much was SpecialtyCare acquired for? | SpecialtyCare was acquired for $1.3B in October 2021. |
| How much funding has SpecialtyCare raised? | SpecialtyCare has raised $600K across 1 funding round. |
| What was SpecialtyCare's last funding round? | SpecialtyCare's last funding round was a $600K seed round in August 2013. |
| Which companies are comparable to SpecialtyCare? | Companies comparable to SpecialtyCare include Pilot, TKC, SMS, IntelyCare, FESCO Group and Zensar Technologies. |
| How many companies has SpecialtyCare acquired? | SpecialtyCare has acquired 5 companies, including Synapse Neuromonitoring, Neuropath, Precedent Health, Sentient Medical Systems and ProNerve. |
See companies similar to SpecialtyCare
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




